You have 9 free searches left this month | for more free features.

Angiotensin Receptor Blockade

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Therapeutic Drug Use for CKD Patients

Active, not recruiting
  • Chronic Kidney Disease
  • angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT2 inhibitors, calcium channel blockers, β Receptor blocker
  • Jinan, Shandong, China
    Xiao Li,MD
Apr 18, 2023

Renin Angiotensin Aldosterone System Genetic Polymorphism on

Recruiting
  • Myocardial Infarction
    • Cairo, Egypt
      Ain Shams University
    May 16, 2023

    Aortic Valve Stenosis Trial in Seoul (Angiotensin Receptor-Neprilysin Inhibitor, antihypertensive drugs including RAS inhibitors

    Not yet recruiting
    • Aortic Valve Stenosis
    • Angiotensin Receptor-Neprilysin Inhibitor
    • antihypertensive drugs including RAS inhibitors (ACE inhibitors or ARB)
    • Seoul, Korea, Republic of
      Asan Medical Center
    Jan 4, 2023

    Coarctation of Aorta, High Blood Pressure Trial in Rochester (Losartan, Amlodipine, Placebo)

    Not yet recruiting
    • Coarctation of Aorta
    • High Blood Pressure
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 21, 2023

    Novel Antidiabetic Drug Combined With Angiotensin

    Recruiting
    • Type 2 Diabetes
    • Antidiabetic Drugs
      • Beijing, Beijing, China
      • +1 more
      Jun 20, 2023

      Aortic Valve Stenosis, Valsartan, Angiotensin Receptor Antagonists Trial in Limoges (Valsartan, Placebo Oral Tablet)

      Not yet recruiting
      • Aortic Valve Stenosis
      • +5 more
      • Limoges, France
        Limoges university hospital
      Dec 23, 2022

      Angiotensin Converting Enzyme Inhibitors and Angiotensin

      Not yet recruiting
      • COVID-19 Pneumonia
      • Covid_19
      • (no location specified)
      Jun 5, 2022

      Aortic Stenosis Trial in Québec, Odense (Angiotensin Receptor Blockers, Placebo)

      Recruiting
      • Aortic Stenosis
      • Angiotensin Receptor Blockers
      • Placebo
      • Québec, Quebec, Canada
      • +1 more
      Mar 28, 2022

      Depressive Disorder, MDD, Bipolar Disorder Trial in West Haven (Perampanel 6 MG, Ketamine, Placebo)

      Not yet recruiting
      • Depressive Disorder
      • +4 more
      • Perampanel 6 MG
      • +2 more
      • West Haven, Connecticut
        VA Connecticut Healthcare System
      Mar 14, 2023

      Myocardial Infarction With Non-obstructive Coronary Arteries Trial in Worldwide (Beta blocker, ACEI, ARB)

      Recruiting
      • Myocardial Infarction With Non-obstructive Coronary Arteries
      • Beta blocker
      • +2 more
      • Adelaide, Sout Australi, Australia
      • +19 more
      Sep 6, 2021

      Ehlers-Danlos Syndrome, Vascular Type Trial in France (Irbesartan, Placebo)

      Completed
      • Ehlers-Danlos Syndrome, Vascular Type
      • Bordeaux, France
      • +14 more
      Nov 2, 2020

      Sleep Disordered Breathing, Hypoxia, Respiration; Sleep Disorder Trial in Kelowna (Hyperoxic Hypercapnic Ventilatory Response

      Completed
      • Sleep Disordered Breathing
      • +3 more
      • Hyperoxic Hypercapnic Ventilatory Response Test
      • +5 more
      • Kelowna, British Columbia, Canada
        University of British Columbia
      Sep 2, 2020

      Systemic Right Ventricle, Heart Failure Trial in Montreal (Sacubitril / Valsartan Oral Tablet, Placebo)

      Active, not recruiting
      • Systemic Right Ventricle
      • Heart Failure
      • Sacubitril / Valsartan Oral Tablet
      • Placebo
      • Montreal, Quebec, Canada
        Montreal Heart Institute
      Dec 21, 2022

      Surgery, Angiotensin Hypertension, Perioperative Complication Trial in Netherlands (drug, diagnostic test, behavioral)

      Recruiting
      • Surgery
      • +2 more
      • Perioperative withdrawal of angiotensin converting enzyme inhibitors and angiotenin receptor blockers
      • +4 more
      • Amsterdam, Netherlands
      • +6 more
      Jan 6, 2022

      Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

      Recruiting
      • Kidney Disease
      • Chula Vista, California
      • +5 more
      Jan 23, 2023

      The Effect of RAAS Blockers on ACE2 Levels

      Completed
      • Renin-Angiotensin System
      • ACE inhibitor ,angiotensin receptor blockers
      • Cairo, Select A State Or Province, Egypt
        Ainshams University
      Jun 10, 2022

      Chronic Kidney Allograft Nephropathy Trial in L'Hospitalet de Llobregat (Valsartan 80Mg Oral Tablet)

      Recruiting
      • Chronic Kidney Allograft Nephropathy
      • Valsartan 80Mg Oral Tablet
      • L'Hospitalet de Llobregat, Barcelona, Spain
        Nephrology Department. Hospital Universitari de Bellvitge
      May 17, 2021

      Acute Kidney Injury Trial (IRBESARTAN, tablet, 150 mg, Placebo, tablet, 150 mg)

      Not yet recruiting
      • Acute Kidney Injury
      • IRBESARTAN, tablet, 150 mg
      • Placebo, tablet, 150 mg
      • (no location specified)
      Aug 8, 2022

      Anti-Angiotensin-Receptor 1-, Anti-Endothelin-Receptor

      Completed
      • Cardiac Failure
        • Wetzikon, Switzerland
          GZO Regional Health Center
        Jul 13, 2021

        COVID-19, SARS-CoV2 Infection Trial in India (Candesartan Cilexetil, Repagermanium, Candesartan Placebo)

        Recruiting
        • COVID-19
        • SARS-CoV2 Infection
        • Candesartan Cilexetil
        • +3 more
        • Guntur, India
        • +4 more
        Mar 13, 2022

        Cardiorenal Syndrome (CRS) Trial in Rochester (Candesartan, Placebo)

        Completed
        • Cardiorenal Syndrome (CRS)
        • Rochester, Minnesota
          Mayo Clinic
        Oct 20, 2021

        Coronavirus Disease 2019, COVID-19 Trial in Australia, India (Angiotensin Receptor Blockers, Placebo)

        Completed
        • Coronavirus Disease 2019
        • COVID-19
        • Angiotensin Receptor Blockers
        • Placebo
        • Camperdown, New South Wales, Australia
        • +21 more
        Mar 2, 2022

        Heart Failure With Preserved Ejection Fraction Trial in Chongqing (Angiotensin Receptor-Neprilysin Inhibition, Placebo)

        Not yet recruiting
        • Heart Failure With Preserved Ejection Fraction
        • Angiotensin Receptor-Neprilysin Inhibition
        • Placebo
        • Chongqing, China
          The first affiliated Hospital of Chongqing Medical University
        Oct 21, 2021

        Chronic Kidney Disease, Blood Pressure, Angiotensin-converting Enzyme Inhibitor Trial in San Francisco (Continuation of ACEi

        Active, not recruiting
        • Chronic Kidney Disease
        • +3 more
        • Continuation of ACEi and/or ARBs
        • San Francisco, California
          University of California, San Francisco
        Oct 4, 2021

        MDD, Childhood Trauma Trial in Amsterdam (Mifepristone, Placebo)

        Recruiting
        • Major Depressive Disorder
        • Childhood Trauma
        • Amsterdam, Noord-Holland, Netherlands
          Amsterdam UMC, location VUmc
        Mar 17, 2022